Toward increasing relevance of the US Army's deployment cycle resilience training: A quality improvement evaluation

Abstract: Introduction: The Deployment Cycle Resilience Training (DCRT) is a rebranded and revised version of the initial deployment resilience training called Battlemind, that was in effect from 2014 to 2018. Methods: To maintain the relevance and utility of resilience training centred on the deployment cycle, the current version of DCRT was formally evaluated using mixed methodologies by the Walter Reed Army Institute of Research. Results: The evaluation team found that both soldiers and their spouses reported predominantly positive ratings for the pre-deployment and reintegration modules of the training. In addition to reporting the training to be satisfactory and relevant and reporting an intention to apply the skills beyond the deployment cycle, soldiers and spouses also identified areas for improvement related to addressing the training's relevancy and relatability. Discussion: To continue improving the training, the evaluation team recommends that the training include more examples from the army reserve and the National Guard, and that the support network (i.e., circle of support) be widened beyond spouses. These, and additional recommendations, are further discussed.

Read the full article
Report a problem with this article

Related articles

  • More for Researchers

    Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data

    Abstract: Novel and automated means of opioid use and relapse risk detection are needed. Unstructured electronic medical record data, including written progress notes, can be mined for clinically relevant information, including the presence of substance use and relapse-critical markers of risk and recovery from opioid use disorder (OUD). In this study, we used natural language processing (NLP) to automate the extraction of opioid relapses, and the timing of these occurrences, from veteran patients' electronic medical record. We then demonstrated the utility of our NLP tool via analysis of pre-/post-COVID-19 opioid relapse trends among veterans with OUD. For this demonstration, we analyzed data from 107,606 veterans OUD enrolled in Veterans Health Administration, comparing a pandemic-exposed cohort (n = 53,803; January 2019-March 2021) to a matched prepandemic cohort (n = 53,803; October 2017-December 2019). The recall of our NLP tool was 75% and our precision was 94%, demonstrating moderate sensitivity and excellent specificity. Using the NLP tool, we found that the odds of opioid relapse postpandemic onset were proportionally higher compared to prepandemic trends, despite patients having fewer mental health encounters from which to derive instances of relapse postpandemic onset. In this research application of the tool, and as hypothesized, we found that opioid relapse risk was elevated postpandemic. The application of NLP Methods: to identify and monitor relapse risk holds promise for future surveillance, risk prevention, and clinical outcome research.